Immune Therapeutics Inc (OTCQB:IMUN)

0.0255
Delayed Data
As of Jun 22
 +0.0014 / +5.85%
Today’s Change
0.01
Today|||52-Week Range
0.07
+22.64%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$7.8M

Company Description

Immune Therapeutics, Inc. is a biopharmaceutical company focuses on the commercialization of affordable non-toxic immunotherapies focused on the activation and rebalancing of the body's immune system. It specializes in the treatment of cancers, HIV, autoimmune diseases, inflammatory conditions, and other opportunistic infections for chronic often life-threatening diseases through the mobilization of the body's immune system in emerging nations using existing clinical data. The company was founded by Noreen Griffin on December 2, 1993 and is headquartered in Orlando, FL.

Contact Information

Immune Therapeutics, Inc.
37 North Orange Avenue
Orlando Florida 32801
P:(888) 613-8802
Investor Relations:

Employees

Shareholders

Individual stakeholders14.17%
Mutual fund holders--
Other institutional--

Top Executives

Noreen GriffinChief Executive Officer & Director
Rudy J. WilliamsChief Operating Officer
Peter J. AronstamChief Financial Officer
Fengping ShanChief Science Officer
Joseph M. FortunakVice President-Global Research & Development